In reply-Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers.

Sanchis-Gomar, Fabian; Lavie, Carl J; Perez-Quilis, Carme; Henry, Brandon M; Lippi, Giuseppe

Sanchis-Gomar, Fabian; Lavie, Carl J; Perez-Quilis, Carme; Henry, Brandon M; Lippi, Giuseppe.

Sanchis-Gomar F; University of Valencia and INCLIVA Biomedical Research Institute, Spain; Stanford University School of Medicine, Stanford, CA.
Lavie CJ; John Ochsner Heart and Vascular Institute, Ochsner Clinical School The University of Queensland School of Medicine, New Orleans, LA.
Perez-Quilis C; University of Valencia and INCLIVA Biomedical Research Institute, Valencia, Spain.
Henry BM; The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Lippi G; University of Verona, Verona, Italy.

Mayo Clin Proc ; 95(7): 1553-1556, 2020 07.

Article in English | MEDLINE | ID: covidwho-647624

Subject(s)

Angiotensin Receptor Antagonists; Coronavirus Infections; Coronavirus; Pandemics; Pneumonia, Viral; Angiotensin Receptor Antagonists/therapeutic use; Angiotensin-Converting Enzyme Inhibitors/therapeutic use; Angiotensins; Antihypertensive Agents/therapeutic use; Betacoronavirus; COVID-19; Humans; Inflammation/drug therapy; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Coronavirus / Angiotensin Receptor Antagonists / Pandemics Limits: Humans Language: English Journal: Mayo Clin Proc Year: 2020 Document Type: Article Affiliation country: J.mayocp.2020.05.003

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google